Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host-disease-associated autoimmunity

ABSTRACT: Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host-disease-associated autoimmunity

PROVIDER: PRJNA661763 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12601007.fastq.gz	Fastqsanger.gz
	SRR12601008.fastq.gz	Fastqsanger.gz
	SRR12601009.fastq.gz	Fastqsanger.gz
	SRR12601010.fastq.gz	Fastqsanger.gz
	SRR12601011.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 14

Similar Datasets

Graft versus host disease treatment with mesenchymal stem cells

Project description:graft versus host disease organoids were co-cultured with mesenchymal stem cells

2024-05-22 | PXD034822 | Pride

Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host disease-associated autoimmunity.

Project description: Not available

| S-EPMC7773409 | biostudies-literature

GZMK-expressing tissue-resident memory CD8+ T cells mediate human intestinal acute graft-versus-host disease

Project description:Tissue-resident memory T cells (TRM) have recently emerged as crucial cellular players for murine acute graft-versus-host disease (aGVHD) development. However, the role of distinct subsets of CD8+TRM cells in human intestinal aGVHD is not well known yet. Herein,we combined multiplex immunohistochemical staining with single-cell RNA sequencing to elucidate the differentiation trajectory, lineage commitment, clonal expansion and functional properties of distinct CD8+TRM cell subsets in human intestinal aGVHD. We revealed seven functionally distinct CD8+TRM subsets and innovatively uncovered a significant GZMK+CD8+TRM subset. GZMK+CD8+TRM subset mediated human intestinal aGVHD by exhibiting enhanced clonal expansion, IFN signaling pathway-associated proinflammatory, and lineage bifurcation differentiation properties. High GZMK+CD8+TRM subset infiltration is correlated with human intestinal aGVHD severity and poor prognosis. Therefore, we demonstrated that human intestinal aGVHD is in good part mediated by pivotal GZMK+CD8+TRM subset. Targeting key CD8+TRM cell subsets could be a new treatment approach in the human intestinal aGVHD.

2026-05-06 | GSE284015 | GEO

FRCs promote Treg function in acute graft-versus-host disease (aGvHD)

Project description:FRCs promote Treg function in acute graft-versus-host disease (aGvHD)

| PRJNA706037 | ENA

GZMK-expressing tissue-resident memory CD8+ T cells mediate human intestinal acute graft-versus-host disease [INT]

2026-05-06 | GSE318630 | GEO

GZMK-expressing tissue-resident memory CD8+ T cells mediate human intestinal acute graft-versus-host disease

Project description:GZMK-expressing tissue-resident memory CD8+ T cells mediate human intestinal acute graft-versus-host disease

| PRJNA1196840 | ENA

Graft Source-dependent Biomarkers for Risk of Chronic Graft-Versus-Host Disease and Death

Project description:We identify risk markers and graft specific markers at day 90 post-HCT (hematopoietic cell transplant). For this, we developed a 4-plex TMT plasma proteomic approach comparing day-90 samples from PB (peripheral-blood stem cells) graft recipients who developed cGVHD by day 180, PB graft recipients who did not develop cGVHD, BM (bone marrow) graft recipients who developed cGVHD by day 180, BM graft recipients who did not developed cGVHD. Five markers were candidate risk markers and selected to move to the validation phase. Using ELISA assays these 5 markers were measured along with nine previously identified cGVHD proteomic biomarkers (ST2, CXCL9, MMP3, OPN, CXCL10, soluble CD163, IL17, B-cell activating factor (BAFF), and C-C-motif-chemokine-15 (CCL15)16,23-29 in 335 recipients (from CTN0201 to test if they were markers of risk and graft-specific markers). Finally, we measured the six significant candidate risk markers in CTN0201 in 653 patients from the CTN1202 study, an independent contemporary cohort.

2021-12-17 | MSV000088585 | MassIVE

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Project description:RATIONALE: Beclomethasone may be an effective treatment for graft-versus-host disease. PURPOSE: Phase I/II trial to study the effectiveness of beclomethasone in treating patients who have graft-versus-host disease of the esophagus, stomach, small intestine, or colon.

| 2005776 | ecrin-mdr-crc

6-phosphogluconate dehydrogenase blockade in T Cells mitigates acute graft-versus-host disease while preserving graft-versus-tumor activity

Project description:6-phosphogluconate dehydrogenase blockade in T Cells mitigates acute graft-versus-host disease while preserving graft-versus-tumor activity

| PRJNA1225717 | ENA

Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host-disease-associated autoimmunity

Project description:We report application of RNA-seqencing to investigate PSGL1hi and PSGL1lo CD4+T cells transcriptional difference in the GVHD target tissues of spleen, liver and lung at day 30 after HCT.

2020-12-31 | GSE157566 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data